Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

YS Biopharma Co., Ltd. YS

Full chart Compare
Set alert

Price alert · YS

All alert types
1.02 +1.02

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-1.78 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -5.5×
FY 2021: -9.3×FY 2022: -3329×FY 2023: -5.8×FY 2024: -1.3×FY 2025: -5.5×
FY 2021 5y median -5.8× FY 2025
P/S 0.9×
FY 2021: 6.9×FY 2022: 3.6×FY 2023: 1.2×FY 2024: 1.0×FY 2025: 0.9×
FY 2021 5y median 1.2× FY 2025
P/B 1.1×
FY 2021: 83594×FY 2022: 10.1×FY 2023: 1.2×FY 2024: 1.0×FY 2025: 1.1×
FY 2021 5y median 1.2× FY 2025
P/FCF -4.0×
FY 2021: -5.1×FY 2022: -6.1×FY 2023: -3.6×FY 2024: -1.7×FY 2025: -4.0×
FY 2021 5y median -4.0× FY 2025
EV/EBITDA -19.4×
FY 2021: -11.9×FY 2022: -32.7×FY 2023: -12.7×FY 2024: -2.0×FY 2025: -19.4×
FY 2021 5y median -12.7× FY 2025
EV/Sales 1.5×
FY 2021: 5.4×FY 2022: 4.4×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.5×
FY 2021 5y median 1.5× FY 2025
FCF Yield -25.0%
FY 2021: -19.7%FY 2022: -16.5%FY 2023: -28.2%FY 2024: -60.6%FY 2025: -25.0%
FY 2021 5y median -25.0% FY 2025

Profitability

Gross Margin 82.5%
FY 2021: 76.8%FY 2022: 76.7%FY 2023: 77.7%FY 2024: 79.5%FY 2025: 82.5%
FY 2021 5y median 77.7% FY 2025
Operating Margin -14.0%
FY 2021: -49.0%FY 2022: -0.1%FY 2023: -20.3%FY 2024: -77.7%FY 2025: -14.0%
FY 2021 5y median -20.3% FY 2025
Net Margin -16.3%
FY 2021: -74.6%FY 2022: -0.1%FY 2023: -21.2%FY 2024: -75.6%FY 2025: -16.3%
FY 2021 5y median -21.2% FY 2025
ROE -20.0%
FY 2021: -897894.8%FY 2022: -0.3%FY 2023: -20.0%FY 2024: -74.1%FY 2025: -20.0%
FY 2021 5y median -20.0% FY 2025
ROIC -9.2%
FY 2021: -17.1%FY 2022: -0.2%FY 2023: -11.1%FY 2024: -41.0%FY 2025: -9.2%
FY 2021 5y median -11.1% FY 2025
ROA -7.3%
FY 2021: -209935.3%FY 2022: -0.3%FY 2023: -8.5%FY 2024: -28.6%FY 2025: -7.3%
FY 2021 5y median -8.5% FY 2025

Growth (YoY)

Revenue 7.2%
FY 2021: 0.0%FY 2022: 95.7%FY 2023: 36.6%FY 2024: -16.6%FY 2025: 7.2%
FY 2021 FY 2025
Operating Income 80.6%
FY 2021: 0.0%FY 2022: 99.6%FY 2023: -25280.1%FY 2024: -219.9%FY 2025: 80.6%
FY 2021 FY 2025
EPS (diluted) 76.8%
FY 2021: 0.0%FY 2022: 99.7%FY 2023: -10062.2%FY 2024: -115.4%FY 2025: 76.8%
FY 2021 FY 2025
Free Cash Flow 59.1%
FY 2021: 0.0%FY 2022: 14.8%FY 2023: 20.0%FY 2024: -41.7%FY 2025: 59.1%
FY 2021 FY 2025

Financial Health

Current Ratio 1.0×
FY 2021: 10473×FY 2022: 7.2×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 1.0×
FY 2021 5y median 1.6× FY 2025
Quick Ratio 0.7×
FY 2021: 9310×FY 2022: -1160×FY 2023: 1.3×FY 2024: 0.9×FY 2025: 0.7×
FY 2021 5y median 0.9× FY 2025
Debt / Equity 0.8×
FY 2021: 0.2×FY 2022: 2.1×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.8×
FY 2021 5y median 0.7× FY 2025
Net Debt / EBITDA -8.0×
FY 2021: 3.3×FY 2022: -5.7×FY 2023: -1.7×FY 2024: -0.5×FY 2025: -8.0×
FY 2021 5y median -1.7× FY 2025
Interest Coverage -5.5×
FY 2021: -4.2×FY 2022: -0.2×FY 2023: -4.5×FY 2024: -10.1×FY 2025: -5.5×
FY 2021 5y median -4.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-03-31